← Open Payments lookup

RAJWINDER KAUR: Open Payments

NPI 1083265565 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,150 in 44 payments from 14 companies in 2025. Trend: 2023 $1,481 · 2024 $1,208 · 2025 $1,150

Food & beverage: $1,150
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$275
Amgen Inc.7$138
GENZYME CORPORATION1$118
Verona Pharma, Inc.4$117
GlaxoSmithKline, LLC.5$109
United Therapeutics Corporation4$88
Actelion Pharmaceuticals US, Inc.3$76
Boehringer Ingelheim Pharmaceuticals, Inc.2$55
Electromed, Inc.3$48
Insmed, Inc.2$44

Products named: TEZSPIRE, DUPIXENT, Ohtuvayre, FASENRA, Tyvaso, AIRSUPRA, NUCALA, OPSUMIT.

Industry payments across CA — which companies pay providers there.